Prophylactic methylprednisolone to reduce inflammation and improve outcomes from one lung ventilation in children: a

Mary C Theroux1, Alicia Olivant Fisher, Maria E Rodriguez

  • 1Department of Anesthesiology and Critical Care Medicine, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA; Department of Anesthesiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA; Department of Pediatrics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA.

Paediatric Anaesthesia
|January 6, 2015
PubMed

Insights

A single dose of methylprednisolone given before one lung ventilation (OLV) improved physiological stability in children. This intervention reduced respiratory complications and modulated inflammatory markers, indicating its potential to minimize lung injury during OLV.

Area of Science:

  • Pediatric Anesthesiology
  • Thoracic Surgery
  • Pharmacology

Background:

  • One lung ventilation (OLV) can cause significant inflammatory and mechanical lung injury in children, leading to complications.
  • Currently, no interventions are established to mitigate OLV-induced lung injury in pediatric patients.

Purpose of the Study:

  • To investigate the efficacy of a single pre-operative dose of methylprednisolone in reducing lung injury and improving physiological stability during OLV in children.
  • To test the hypothesis that methylprednisolone administration 45-60 minutes before lung collapse would minimize injury.

Main Methods:

  • A randomized, placebo-controlled trial involving 28 children undergoing OLV.
  • Participants received either 2 mg·kg(-1) methylprednisolone (MP) or a saline placebo prior to OLV.
  • Physiological parameters (bronchospasm, resistance, compliance) and plasma inflammatory markers were monitored.

Main Results:

  • The methylprednisolone group exhibited lower respiratory resistance compared to the placebo group (P=0.04).
  • Pro-inflammatory IL-6 levels were significantly lower, and anti-inflammatory IL-10 levels were higher in the methylprednisolone group (P=0.01 and P=0.001, respectively).
  • Lower tryptase levels were observed in the methylprednisolone group post-OLV (P=0.03), with no reported side effects.

Conclusions:

  • A single 2 mg·kg(-1) dose of methylprednisolone prior to OLV enhances physiological stability in pediatric patients.
  • Methylprednisolone effectively reduces pro-inflammatory markers and increases anti-inflammatory markers, suggesting a protective role against OLV-induced lung injury.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation